RxDoctor Payments Data

Parthiv Sheth, MD

Psychiatry · Gloucester, VANPI 1184685877

Payments from drug & device makers

$2,608in general payments, 2019–2025

Across 135 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$530
  • Alkermes, Inc.$247
  • Otsuka America Pharmaceutical, Inc.$236
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$226
  • Neurocrine Biosciences, Inc.$217
  • AbbVie$207
  • plus $944 from 10 others

What the payments were for

  • Food & beverage$2,58399%
  • Education$251%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,608 in reported general payments places this provider in the 85th percentile of 884 psychiatry providers in Virginia.

See all psychiatry providers in Virginia

Medicare billing

Part B allowed, 2024
$11,653
Medicare patients
67
Services billed
323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega TrinzaPaliperidone Palmitate27$175,255
Abilify AsimtufiiAripiprazole12$69,660
VraylarCariprazine Hcl18$25,133
FanaptIloperidone12$19,469
Asenapine Maleate62$15,785
Aripiprazole116$13,243
Chlorpromazine Hcl102$13,044
Clozapine96$12,260
TrintellixVortioxetine Hydrobromide23$11,082
Paliperidone ErPaliperidone26$8,401
Lurasidone Hcl29$6,445
Quetiapine Fumarate ErQuetiapine Fumarate109$3,856
Duloxetine Hcl126$3,797
Quetiapine Fumarate212$3,405
Oxcarbazepine46$3,170

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza$530$175,25527 claims
Otsuka America Pharmaceutical, Inc.Abilify Asimtufii$236$69,66012 claims
AbbVieVraylar$207$25,13318 claims
Vanda Pharmaceuticals Inc.Fanapt$195$19,46912 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$36$11,08223 claims
Teva Pharmaceuticals USA, Inc.Loxapine$173$2,10222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 884 psychiatry providers in Virginia.

Other psychiatry in Gloucester

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →